Primary sclerosing cholangitis (PSC) is a heterogeneous cholangiopathy characterized by progressive biliary
fibrosis.
RNA sequencing of liver tissue from patients with PSC (n = 74) enrolled in a 96-week clinical trial was performed to identify associations between
biological pathways that were independent of
fibrosis and clinical events.
APPROACH AND RESULTS: The effect of
fibrosis was subtracted from gene expression using a computational approach. The
fibrosis-adjusted gene expression patterns were associated with time to first PSC-related clinical event (e.g.,
cholangitis, hepatic decompensation), and differential expression based on risk groups and Ingenuity Pathway Analysis were performed. Baseline demographic data were representative of PSC: median age 48 years, 71% male, 49% with
inflammatory bowel disease, and 44% with bridging
fibrosis or
cirrhosis. The first principle component (PC1) of
RNA-sequencing data accounted for 18% of variance and correlated with
fibrosis stage (ρ = -0.80; P < 0.001). After removing the effect of
fibrosis-related genes, the first principle component was not associated with
fibrosis (ρ = -0.19; P = 0.11), and a semisupervised clustering approach identified two distinct patient clusters with differential risk of time to first PSC-related event (P < 0.0001). The two groups had similar
fibrosis stage, hepatic
collagen content, and α-smooth muscle actin expression by morphometry, Enhanced
Liver Fibrosis score, and serum liver biochemistry,
bile acids, and
IL-8 (all P > 0.05). The top pathways identified by Ingenuity Pathway Analysis were eukaryotic translation inhibition factor 2 (
eIF2) signaling and regulation of eIF4/
p70S6K signaling. Genes involved in the unfolded protein response,
activating transcription factor 6 (ATF6) and
eIF2, were differentially expressed between the PSC clusters (down-regulated in the high-risk group by log-fold changes of -0.18 [P = 0.02] and -0.16 [P = 0.02], respectively). Clinical events were enriched in the high-risk versus low-risk group (38% [12/32] vs. 2.4% [1/42], P < 0.0001).
CONCLUSIONS: Removing the contribution of
fibrosis-related pathways uncovered alterations in the unfolded protein response, which were associated with liver-related complications in PSC.